Literature DB >> 2685751

Point mutation in codon 61 of N-RAS genes in human myeloma cell lines.

M Sawada1, S Shimizu, T Arai, S Konda, N Enomoto, T Date.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2685751      PMCID: PMC335060          DOI: 10.1093/nar/17.21.8867

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  6 in total

1.  Activation of N-ras in a human melanoma cell line.

Authors:  R A Padua; N C Barrass; G A Currie
Journal:  Mol Cell Biol       Date:  1985-03       Impact factor: 4.272

2.  Analysis of RAS oncogene mutations in human lymphoid malignancies.

Authors:  A Neri; D M Knowles; A Greco; F McCormick; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

3.  Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes.

Authors:  C J Farr; R K Saiki; H A Erlich; F McCormick; C J Marshall
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

4.  Mechanism of activation of an N-ras gene in the human fibrosarcoma cell line HT1080.

Authors:  R Brown; C J Marshall; S G Pennie; A Hall
Journal:  EMBO J       Date:  1984-06       Impact factor: 11.598

5.  Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines.

Authors:  S Shimizu; R Yoshioka; Y Hirose; S Sugai; J Tachibana; S Konda
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

6.  Mutations of N-ras oncogene in myelodysplastic syndromes and leukemias detected by polymerase chain reaction.

Authors:  H Mano; F Ishikawa; H Hirai; F Takaku
Journal:  Jpn J Cancer Res       Date:  1989-02
  6 in total
  1 in total

1.  The Ras1-mitogen-activated protein kinase signal transduction pathway regulates synaptic plasticity through fasciclin II-mediated cell adhesion.

Authors:  Young-Ho Koh; Catalina Ruiz-Canada; Michael Gorczyca; Vivian Budnik
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.